Premium
Acne: a side‐effect of masculinizing hormonal therapy in transgender patients
Author(s) -
Motosko C.C.,
Zakhem G.A.,
Pomeranz M.K.,
Hazen A.
Publication year - 2019
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.17083
Subject(s) - acne , transgender , medicine , testosterone (patch) , hormonal therapy , population , dermatology , gender dysphoria , incidence (geometry) , endocrinology , psychology , cancer , prostate cancer , physics , environmental health , psychoanalysis , optics
Summary Background Masculinizing hormonal treatment in transgender men has the potential to increase the level of androgens at end organs, including the pilosebaceous unit. Androgen‐induced sebocyte growth and differentiation, sebum production and infundibular keratinization may underlie the development of acne vulgaris among patients receiving this therapy. Objectives The aim of this article is to familiarize dermatologists with the sensitivities and challenges of treating acne in transgender male individuals. Methods This review article discusses the pathogenesis and treatment of acne in transgender men on testosterone therapy and highlights the unique considerations in treating this underserved patient population. Results Despite the incidence of treatment‐related acne and the unique considerations in treating transgender men, studies addressing this topic among this patient population are limited. Conclusions Generally, the standard guidelines for the treatment of acne can be followed in treating these patients; however, several medical, social and psychological factors should be considered.